Policy / Pricing Italy leads the way on child genetic disease diagnosis PharmaphorumA scheme to hasten the diagnosis of children with genetic disorders is achieving strong results and could be a template for national health systems.Policy / PricingRare DiseaseRead full story pharminent April 21, 2026 (Last updated: April 21, 2026) Pharmaphorum A scheme to hasten the diagnosis of children with genetic disorders is achieving strong results and could be a template for national health systems. Policy / PricingRare DiseaseRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Asahi Kasei acquires German company AicurisNext: Pfizer and Astellas secure FDA priority review for Padcev MIBC combo therapy Related Stories Policy / Pricing Decoding Medicare Advantage Coding Intensity pharminent July 1, 2026 Policy / Pricing UK partners with Eli Lilly on obesity plan pharminent June 29, 2026 Policy / Pricing EFPIA report adds to pressures on EU drug pricing policy pharminent June 24, 2026
